Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet
NCT03074058
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Clinical Pharmacology
Interventions
DRUG:
Fosrenol ODT (Lanthanum Carbonate, BAY77-1931)
DRUG:
Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)
Sponsor
Bayer